NCT03244956 2021-09-28
MERAIODE
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2 Unknown
Clinical Trials
1 trialsMetastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation × Thyrotropin Alfa × Head & Neck × Clear all